We have previously published on the importance of epidermal growth factor receptor (EGFR/ErbB1) signalling, particularly in ErbB2 overexpressing DCIS and also the role for Notch signalling in regulating DCIS cancer stem/progenitor cells [10]. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.